Cohance Lifesciences Limited (BOM:543064)
879.35
+9.10 (1.05%)
At close: Aug 29, 2025
Cohance Lifesciences Market Cap
Cohance Lifesciences has a market cap or net worth of 336.89 billion as of August 29, 2025. Its market cap has increased by 36.07% in one year.
Market Cap
336.89B
Enterprise Value
338.32B
Revenue
12.59B
Ranking
n/a
PE Ratio
139.57
Stock Price
879.35
Market Cap Chart
Since March 9, 2020, Cohance Lifesciences's market cap has increased from 33.71M to 336.89B, an increase of 999,421.21%. That is a compound annual growth rate of 437.89%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 28, 2025 | 333.46B | 15.03% |
Dec 31, 2024 | 289.89B | 57.55% |
Dec 29, 2023 | 184.00B | 46.05% |
Dec 30, 2022 | 125.98B | 0.33% |
Dec 31, 2021 | 125.56B | 9.05% |
Dec 31, 2020 | 115.14B | 341,510.23% |
Mar 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Reliance Industries | 18.75T |
HDFC Bank | 14.71T |
Tata Consultancy Services | 11.42T |
Bharti Airtel | 11.28T |
ICICI Bank | 9,990.86B |
State Bank of India | 7,402.49B |
Hindustan Unilever | 6,326.51B |
Infosys | 6,218.32B |